financetom
Business
financetom
/
Business
/
Architectural products firm Apogee Q2 net sales beat estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Architectural products firm Apogee Q2 net sales beat estimates
Oct 9, 2025 3:43 PM

Overview

* Apogee Enterprises Inc ( APOG ) Q2 net sales rise 4.6% to $358 mln, beating analyst expectations

* Adjusted EPS for Q2 beats analyst expectations at $0.98

* Company's Q2 adjusted EBITDA margin fell due to lower prices and unfavorable mix

Outlook

* Company expects fiscal 2026 net sales of $1.39 bln to $1.42 bln

* Apogee forecasts fiscal 2026 diluted EPS of $2.79 to $3.19

* Company projects fiscal 2026 adjusted diluted EPS of $3.60 to $3.90

Result Drivers

* INORGANIC GROWTH - Acquisition of UW Solutions contributed $24.9 mln to net sales, boosting Performance Surfaces segment

* HIGHER COSTS - Gross margin decreased due to higher material, tariff, and health insurance costs, partially offset by lower incentive compensation expense

* ARCHITECTURAL SERVICES - Increased volume in Architectural Services drove segment sales growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $358.19 $351.70

mln mln (4

Analysts

)

Q2 Beat $0.98 $0.84 (4

Adjusted Analysts

EPS )

Q2 EPS $1.10

Q2 Net $23.64

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the construction supplies & fixtures peer group is "buy"

* Wall Street's median 12-month price target for Apogee Enterprises Inc ( APOG ) is $51.75, about 16.3% above its October 8 closing price of $43.32

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
WisdomTree Reports February Net Flows of $512 Million
WisdomTree Reports February Net Flows of $512 Million
Mar 11, 2024
09:37 AM EDT, 03/11/2024 (MT Newswires) -- WisdomTree ( WT ) reported February net flows Monday of $512 million, bringing total assets under management to about $102.86 billion. The company said its cryptocurrency product suite reached more than $100 million of annual net inflows, contrbuting to roughly $700 million in AUM at the month's end. Price: 8.5, Change: +0.08, Percent...
US FDA approves Novo Nordisk's Wegovy for lowering heart risks
US FDA approves Novo Nordisk's Wegovy for lowering heart risks
Mar 11, 2024
(Reuters) -The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes. Novo's widely used diabetes drug Ozempic and weight-loss drug Wegovy, both chemically known as semaglutide, belong to a class of drugs called GLP-1 agonists. Originally developed...
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
Mar 11, 2024
Monday, Aprea Therapeutics Inc ( APRE ) announced that the FDA has cleared its Investigational New Drug (IND) application for APR-1051. “APR-1051 is a next-generation inhibitor of WEE1 kinase, and based on its unique characteristics, we believe it will be best in class,” said Oren Gilad, President and CEO of Aprea. “We look forward to evaluating therapeutic activity in patients, focusing on Cyclin...
Wayfair Insider Sold Shares Worth $598,968, According to a Recent SEC Filing
Wayfair Insider Sold Shares Worth $598,968, According to a Recent SEC Filing
Mar 11, 2024
09:39 AM EDT, 03/11/2024 (MT Newswires) -- Niraj Shah, 10% Owner, Director, Chief Executive Officer, on March 07, 2024, sold 10,000 shares in Wayfair ( W ) for $598,968. Following the Form 4 filing with the SEC, Shah has control over a total of 271,994 shares of the company, with 249,137 shares held directly and 22,857 shares controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved